Psoas sheath block versus suprainguinal fascia iliaca block for pain after hip replacement
Official title: Evaluating the Efficacy of the Psoas Sheath Block for Post Operative Analgesia Following Hip Arthroplasty
Run by University College Hospital Galway · NCT07453498 · Data updated 2026-11-12
This trial will test whether a psoas sheath block provides better pain relief than a suprainguinal fascia iliaca plane block for adults having elective total hip replacement.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 130 (estimated) |
| Sponsor | University College Hospital Galway Academic / other |
| Locations | 1 site (Galway) |
| Status | Recruiting |
| Started | November 18, 2025 |
| Main results expected | November 18, 2027 |
| Study ends | November 18, 2027 |
| Registry record updated | March 6, 2026 |
| Trial ID | NCT07453498 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults over 18 scheduled for elective unilateral total hip replacement who are ASA I-III, willing to receive regional anaesthesia, and able to provide informed consent are eligible.
✕Probably not a fit
Patients with allergy to study medications, chronic high-dose opioid use, active infection at the injection site, coagulopathy or on anticoagulants, or neurological conditions affecting the lower limbs are unlikely to benefit or be eligible.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This single-centre, assessor-blind, randomized controlled trial at Merlin Park Hospital, Galway will compare two regional anaesthesia techniques for postoperative analgesia after elective unilateral total hip arthroplasty. Participants will be randomly assigned to receive either a psoas sheath block (experimental) or a suprainguinal fascia iliaca plane block (control) with allocation concealed in opaque sealed envelopes. The outcome assessor will be blinded to group allocation and common outcomes will include postoperative pain scores and opioid consumption. The trial focuses on adults (ASA I-III) willing to receive regional blocks and provide informed consent.
Why it matters
Potential benefit: If successful, the psoas sheath block could provide better pain control and reduce opioid use after hip replacement, potentially improving recovery and mobility.
How similar studies have gone: Regional blocks such as fascia iliaca and psoas compartment techniques have been shown to reduce pain and opioid need after hip surgery, but direct comparisons between psoas sheath and suprainguinal fascia iliaca blocks are limited.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Participants aged \>18 * Patients scheduled to undergo elective unilateral total hip replacement (THR) surgery. * Patients who agree to receive regional anaesthetic blocks as part of their post-operative pain management. * Physical Status: ASA (American Society of Anesthesiologists) physical status classification I-III. * Patients who are willing and able to provide informed consent, demonstrating an understanding of the trial's purpose, methods, and potential risks. * Patients who are willing to comply with assessments post-surgery Exclusion Criteria: * Allergy to Study Medications * History of chronic opioid use (\>50mg of oral morphine equivalents per day. * Any neurological condition affecting the lower extremities (e.g., peripheral neuropathy, radiculopathy) that could interfere with pain assessment or recovery evaluation. * Infection at Injection Site * Coagulopathy or Anticoagulant Use: Patients with coagulopathy (INR \>1.5) or who are on anticoagulant therapy that cannot be safely discontinued for the block procedure. * Severe Respiratory or Cardiovascular Disease: Any severe respiratory or cardiovascular disease (e.g., severe chronic obstructive pulmonary disease, heart failure) that may increase perioperative risk and complicate recovery. * Cognitive impairment or conditions (e.g., dementia with MMSE \<24) that would prevent reliable pain reporting or compliance with post-operative assessments
Where it's running
-
Merlin Park Hospital, Galway
Galway, Ireland Recruiting
Study contacts
- Study coordinator: Anna L Horgan, MC BCh BAO FCAI
- Email: annahorgan2@gmail.com
- Phone: +353857848200
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Suzetrigine for pain control after primary total hip replacement
This will test whether taking Suzetrigine before surgery and for seven days afterward reduces opioid use and improves pain control in adults having a primary total hip replacement.
-
Choose to Move Replacement Ready for OA patients waiting for hip or knee replacement
This program tests a tailored, online version of a 3-month activity and social-connection plan for older adults with hip or knee osteoarthritis who are waiting for joint replacement surgery to see if it improves physical activity and health while they wait.
-
Foot core exercises after total hip replacement
This trial tests whether adding foot core exercises to the usual hip rehab helps improve foot and leg strength, balance, and foot structure in people who recently had a hip replacement.
-
Dressing Type and Change Frequency for Healing Wounds After Hip Replacement
This study tests whether a VACUTEX capillary-action dressing or standard dressings with different change intervals help wounds heal faster after a primary total hip arthroplasty in adults 65 and older.
-
Tipmed™ Primary Hip Prosthesis: 24-Month Post-Market Follow-Up in Adults
This PMCF study tests the safety and 24‑month performance of the Tipmed hip prosthesis in adults undergoing primary hip replacement.
-
Post-op prednisone vs standard steroid regimen after knee or hip replacement
This study tests a 5-day oral prednisone course after knee or hip replacement to see if pain, swelling, and glucose control are better or different than the usual intraoperative steroid approach.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.